Other work has shown a vital role for galectin-3 in regulation of insulin receptor responsiveness [36,37], and suggests that treatment with ARSB and enhanced binding of galectin-3 with less sulfated C4S may lessen insulin resistance. The gene discussed is INSR; the disease is Insulin resistance.